HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Shuji Nakamura Selected Research
Shuji Nakamura Research Topics
Disease
4
Type 2 Diabetes Mellitus (MODY)
03/2017 - 12/2014
3
Hypertension (High Blood Pressure)
11/2008 - 12/2006
2
Neoplasms (Cancer)
11/2016 - 05/2011
2
Periodontitis
10/2009 - 02/2008
2
Myocardial Infarction
10/2003 - 07/2002
2
Chest Pain (Chest Pains)
02/2003 - 07/2002
1
Melanoma (Melanoma, Malignant)
01/2017
1
Experimental Melanoma
01/2017
1
Hypopigmentation (Hypomelanosis)
01/2017
1
Hypoglycemia (Reactive Hypoglycemia)
01/2015
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2012
1
Diabetic Nephropathies (Diabetic Nephropathy)
06/2010
1
Thrombosis (Thrombus)
06/2010
1
Lymphoma (Lymphomas)
04/2008
1
Leukemia
04/2008
1
Cardiovascular Diseases (Cardiovascular Disease)
12/2006
1
Hyperglycemia
10/2003
1
Infarction (Infarctions)
07/2002
1
Kaposi Sarcoma (Kaposi's Sarcoma)
04/2002
1
Acquired Immunodeficiency Syndrome (AIDS)
04/2002
Drug/Important Bio-Agent (IBA)
3
Glucose (Dextrose)
FDA Link
Generic
01/2015 - 10/2003
2
Insulin Glargine (Lantus)
FDA Link
03/2017 - 09/2016
2
insulin degludec
IBA
03/2017 - 09/2016
2
Acetylcholine (Acetylcholine Chloride)
FDA Link
10/2009 - 02/2008
2
C-Reactive Protein
IBA
10/2009 - 02/2008
2
Nitroprusside (Sodium Nitroprusside)
FDA Link
Generic
10/2009 - 02/2008
2
Interleukin-6 (Interleukin 6)
IBA
10/2009 - 02/2008
1
Hypoglycemic Agents (Hypoglycemics)
IBA
03/2017
1
Sugars
IBA
01/2017
1
Carbohydrates
IBA
01/2017
1
Cyclodextrins
IBA
01/2017
1
Melanins (Melanin)
IBA
01/2017
1
Monophenol Monooxygenase (Tyrosinase)
IBA
01/2017
1
Neutralizing Antibodies
IBA
11/2016
1
3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidine
IBA
01/2015
1
Blood Glucose (Blood Sugar)
IBA
01/2015
1
Liraglutide
FDA Link
12/2014
1
Valsartan (Vals)
FDA Link
01/2012
1
Antibodies
IBA
05/2011
1
Antigens
IBA
06/2010
1
ADAMTS13 Protein
IBA
06/2010
1
von Willebrand Factor
IBA
06/2010
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
10/2009
1
Vasodilator Agents (Vasodilators)
IBA
10/2009
1
Calcium
IBA
11/2008
1
Diuretics
IBA
11/2008
1
Messenger RNA (mRNA)
IBA
04/2008
1
Caffeine (No Doz)
FDA Link
Generic
12/2006
1
Nitroglycerin (Dynamite)
FDA Link
Generic
02/2003
1
Caspase 9
IBA
04/2002
1
Dactinomycin (Actinomycin)
FDA Link
Generic
04/2002
1
Peptide Hydrolases (Proteases)
FDA Link
04/2002
1
Cytochromes c (Cytochrome c)
IBA
04/2002
1
Caspase 8 (Caspase-8)
IBA
04/2002
Therapy/Procedure
6
Therapeutics
11/2016 - 07/2002
1
Biological Therapy
11/2016
1
Immunotherapy
05/2011